ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,305.99
1.13%
Dow Jones
39,893.80
0.85%
US Dollar vs MXN
16.69165
-0.92%
Brent Oil
82.695
0.18%
Bitcoin
66,122.98
7.44%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Tenaya Therapeutics Inc (TNYA)

  7. Tenaya Therapeutics Inc (TNYA) Noticias

TNYA

Tenaya Therapeutics (TNYA)

Tenaya Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TNYA
FechaHoraFuenteTítuloSímboloCompañía
14/05/202415:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNYATenaya Therapeutics Inc
14/05/202415:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNYATenaya Therapeutics Inc
14/05/202415:05GlobeNewswire Inc.Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
02/05/202416:00GlobeNewswire Inc.Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:TNYATenaya Therapeutics Inc
18/03/202415:05GlobeNewswire Inc.Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
18/03/202407:30GlobeNewswire Inc.Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications MedicineNASDAQ:TNYATenaya Therapeutics Inc
27/02/202418:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNYATenaya Therapeutics Inc
27/02/202415:30GlobeNewswire Inc.Tenaya Therapeutics to Participate in Upcoming March Investor ConferencesNASDAQ:TNYATenaya Therapeutics Inc
26/02/202407:30GlobeNewswire Inc.Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature CommunicationsNASDAQ:TNYATenaya Therapeutics Inc
16/02/202419:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TNYATenaya Therapeutics Inc
08/02/202416:25Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNYATenaya Therapeutics Inc
08/02/202407:00GlobeNewswire Inc.Tenaya Therapeutics Announces Pricing of Underwritten OfferingNASDAQ:TNYATenaya Therapeutics Inc
31/01/202415:11Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TNYATenaya Therapeutics Inc
03/01/202407:30GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TNYATenaya Therapeutics Inc
21/11/202315:30GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:TNYATenaya Therapeutics Inc
08/11/202315:05GlobeNewswire Inc.Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
26/10/202307:30GlobeNewswire Inc.Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular CardiomyopathyNASDAQ:TNYATenaya Therapeutics Inc
09/10/202307:30GlobeNewswire Inc.Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific MeetingNASDAQ:TNYATenaya Therapeutics Inc
05/10/202307:30GlobeNewswire Inc.Tenaya Therapeutics Doses First Patient in the MyPeak-1™ Phase 1b Clinical Trial of TN-201 for the Treatment of MYBPC3-Associated Hypertrophic CardiomyopathyNASDAQ:TNYATenaya Therapeutics Inc
02/10/202316:30GlobeNewswire Inc.Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical Potential of Cellular Reprogramming for Cardiac RegenerationNASDAQ:TNYATenaya Therapeutics Inc
21/09/202315:05GlobeNewswire Inc.Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical ConferencesNASDAQ:TNYATenaya Therapeutics Inc
31/08/202315:05GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare ConferenceNASDAQ:TNYATenaya Therapeutics Inc
09/08/202315:05GlobeNewswire Inc.Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
02/08/202315:05GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth ConferenceNASDAQ:TNYATenaya Therapeutics Inc
10/05/202315:36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TNYATenaya Therapeutics Inc
10/05/202315:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TNYATenaya Therapeutics Inc
10/05/202315:19GlobeNewswire Inc.Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
03/05/202307:00GlobeNewswire Inc.Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual MeetingNASDAQ:TNYATenaya Therapeutics Inc
02/05/202307:43Dow Jones NewsTenaya Therapeutics Gets FDA Fast-Track Designation for TN-201NASDAQ:TNYATenaya Therapeutics Inc
02/05/202306:50GlobeNewswire Inc.Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201NASDAQ:TNYATenaya Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TNYA

Su Consulta Reciente

NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
DIS
Walt Disney
NASDAQ
AMZN
Amazon.com
NYSE
AXP
American Express
CCOM
US30
US 30
USOTC
BASFY
BASF (QX)
AMEX
XLE
Energy Select Sector SPDR
USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
AMEX
XLF
Financial Select Sector
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados